Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKesson
Queensland Health
Cipla
US Department of Justice
Chinese Patent Office
Merck
Cantor Fitzgerald
Baxter

Generated: April 25, 2018

DrugPatentWatch Database Preview

OSMOVIST 190 Drug Profile

« Back to Dashboard

Which patents cover Osmovist 190, and what generic alternatives are available?

Osmovist 190 is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in OSMOVIST 190 is iotrolan. Additional details are available on the iotrolan profile page.
Drug patent expirations by year for OSMOVIST 190
Synonyms for OSMOVIST 190
1,3-Benzenedicarboxamide, 5,5'-((1,3-dioxo-1,3-propanediyl)bis(methylimino))bis(N,N'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodo-
16FL47B687
2,4,6-triiodo-5-[methyl-[3-[methyl-[2,4,6-triiodo-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)phenyl]amino]-3-oxopropanoyl]amino]-N,N'-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)carbamoyl]phenyl})carbamoyl]acetamido}-N1,N3-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
3B1-008143
5-[[3-[3,5-bis[[2,3-dihydroxy-1-(hydroxymethyl)propyl]carbamoyl]-2,4,6-triiodo-N-methyl-anilino]-3-oxo-propanoyl]-methyl-amino]-N1,N3-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodo-benzene-1,3-dicarboxamide
5,5'-(Malonylbis(methylimino))bis(N,N'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodoisophthalamide)
5,5'-[(1,3-dioxopropane-1,3-diyl)bis(methylimino)]bis{N,N'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodobenzene-1,3-dicarboxamide}
5,5'-[malonylbis(methylimino)]bis[n,n'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodoisophthalamide]
770I244
79770-24-4
AC1L1GLN
AC1Q3VSR
AC1Q4PLO
AN-36499
C-23915
C37H48I6N6O18
CC-29578
CHEBI:31715
CHEMBL1200555
D01714
D0B8LN
DL 3-117
DL-3117
DR003754
DTXSID0023165
FT-0754152
I663
Iotrol
iotrolan
Iotrolan (JAN/USAN/INN)
Iotrolan [USAN:BAN:INN:JAN]
Iotrolanum
Iotrolanum [Latin]
Iotrolum
Iotrolum [INN-Latin]
Iotrovist
Isovist
Isovist 300 (TN)
LS-29736
OR342582
Osmovist 240
SCHEMBL25535
SH 437
SH-L-437D
UNII-16FL47B687
ZK 39482
ZK-39482

US Patents and Regulatory Information for OSMOVIST 190

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare OSMOVIST 190 iotrolan INJECTABLE;INTRATHECAL 019580-001 Dec 7, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chubb
UBS
Citi
Chinese Patent Office
Teva
Argus Health
US Department of Justice
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.